These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27746370)

  • 1. Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
    Simpson DM; Robinson-Papp J; Van J; Stoker M; Jacobs H; Snijder RJ; Schregardus DS; Long SK; Lambourg B; Katz N
    J Pain; 2017 Jan; 18(1):42-53. PubMed ID: 27746370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
    Vinik AI; Perrot S; Vinik EJ; Pazdera L; Jacobs H; Stoker M; Long SK; Snijder RJ; van der Stoep M; Ortega E; Katz N
    BMC Neurol; 2016 Dec; 16(1):251. PubMed ID: 27919222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
    Burness CB; McCormack PL
    Drugs; 2016 Jan; 76(1):123-34. PubMed ID: 26666418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
    Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
    BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
    van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
    Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
    Kulkantrakorn K; Chomjit A; Sithinamsuwan P; Tharavanij T; Suwankanoknark J; Napunnaphat P
    J Clin Neurosci; 2019 Apr; 62():174-179. PubMed ID: 30472337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety profile of capsaicin 8% patch versus 5% Lidocaine patch in patients with diabetic peripheral neuropathic pain: a randomized, placebo-controlled study of south Asian male patients.
    Hussain N; Said ASA; Javaid FA; Al Haddad AHI; Anwar M; Khan Z; Abu-Mellal A
    J Diabetes Metab Disord; 2021 Jun; 20(1):271-278. PubMed ID: 34178837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
    Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
    Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients.
    Mou J; Paillard F; Turnbull B; Trudeau J; Stoker M; Katz NP
    Clin J Pain; 2014 Apr; 30(4):286-94. PubMed ID: 23765045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia.
    Webster LR; Tark M; Rauck R; Tobias JK; Vanhove GF
    BMC Neurol; 2010 Oct; 10():92. PubMed ID: 20937130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
    Kulkantrakorn K; Lorsuwansiri C; Meesawatsom P
    Pain Pract; 2013 Jul; 13(6):497-503. PubMed ID: 23228119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
    Simpson DM; Estanislao L; Brown SJ; Sampson J
    J Pain Symptom Manage; 2008 Mar; 35(3):299-306. PubMed ID: 17959343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.
    Biesbroeck R; Bril V; Hollander P; Kabadi U; Schwartz S; Singh SP; Ward WK; Bernstein JE
    Adv Ther; 1995; 12(2):111-20. PubMed ID: 10150323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
    Simpson DM; Brown S; Tobias J;
    Neurology; 2008 Jun; 70(24):2305-13. PubMed ID: 18541884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a 0.1% capsaicin hydrogel patch for myofascial neck pain: a double-blinded randomized trial.
    Cho JH; Brodsky M; Kim EJ; Cho YJ; Kim KW; Fang JY; Song MY
    Pain Med; 2012 Jul; 13(7):965-70. PubMed ID: 22681259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: Clinical evidence for pain relief and restoration of function
    Anand P; Privitera R; Donatien P; Fadavi H; Tesfaye S; Bravis V; Misra VP
    Front Neurol; 2022; 13():998904. PubMed ID: 36388188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin in patients with inadequately treated painful diabetic peripheral neuropathy: a randomized withdrawal trial.
    Raskin P; Huffman C; Toth C; Asmus MJ; Messig M; Sanchez RJ; Pauer L
    Clin J Pain; 2014 May; 30(5):379-90. PubMed ID: 23887339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.
    Richter RW; Portenoy R; Sharma U; Lamoreaux L; Bockbrader H; Knapp LE
    J Pain; 2005 Apr; 6(4):253-60. PubMed ID: 15820913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.